(Q34321335)

1 August 2017

1 reference

title

Systemic reactions and fatalities associated with allergen immunotherapy (English)

1 reference

1 August 2017

1 reference

Lockey RF

1

1 reference

1 August 2017

Nicoara-Kasti GL

series ordinal

2

1 reference

1 August 2017

Theodoropoulos DS

series ordinal

3

1 reference

1 August 2017

Bukantz SC

series ordinal

4

1 reference

1 August 2017

publication date

1 July 2001

1 reference

Annals of Allergy, Asthma & Immunology

1 August 2017

published in

1 reference

1 August 2017

volume

87

1 reference

1 August 2017

issue

1 Suppl 1

1 reference

1 August 2017

page(s)

47-55

1 reference

The risk of inducing constitutional reactions in allergic patients

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

The risk of adverse reactions from percutaneous prick-puncture allergen skin testing, venipuncture, and body measurements: data from the second National Health and Nutrition Examination Survey 1976-80 (NHANES II).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Side effects during immunotherapy with purified grass pollen extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

FATAL SYSTEMIC ANAPHYLAXIS IN MAN.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Death during skin testing

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Anaphylactic reaction to desensitisation for allergic rhinitis and asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Anaphylactic reaction to desensitisation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Alternaria IgG precipitins and adverse reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

The hazard of mould hyposensitization in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Failure to detect circulating immune complexes in allergic patients on injection therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

A laboratory evaluation of immune complexes in patients on inhalant immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Extrinsic allergic bronchiolo-alveolitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Haemagglutinating antibodies to cat dander in relation to exposure and respiratory allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Immune complex-mediated disease not a factor in patients on maintenance venom immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Serum sickness triggered by anaphylaxis: a complication of immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Nonorganic adverse reactions to aeroallergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Occurrence of 19S and 7S anti-IgGs during hyperimmunization of rabbits with streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Influence of genetic factors on the magnitude and the heterogeneity of the immune response in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Myeloma proteins (M-components) with antibody-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Repeated stimulation of the reticuloendothelial system and the development of plasma-cell dyscrasias

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Evaluation of the adverse effects of long-term hyposensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Onset of polyarteritis nodosa during allergic hyposensitization treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Abnormal cortisol binding in a case of Waldenström's macroglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Fatalities from immunotherapy (IT) and skin testing (ST)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Survey of fatalities from skin testing and immunotherapy 1985-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

1 reference

7 January 2021

The Hymenoptera venom study. II: Skin test results and safety of venom skin testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

The Hymenoptera venom study. III: Safety of venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Systemic reactions from allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

The waiting period after allergen skin testing and immunotherapy. American Academy of Allergy and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Beta-adrenergic blockers, immunotherapy, and skin testing. American Academy of Allergy and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. American Academy of Allergy and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962195-3

7 January 2021

10.1016/S1081-1206(10)62195-3

Identifiers

DOI

1 reference

1 August 2017

1 reference